Keywords: زمان در محدوده درمانی; Warfarin; Risk models; Time in therapeutic range;
مقالات ISI زمان در محدوده درمانی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: زمان در محدوده درمانی; Atrial fibrillation; Anticoagulation; Vitamin K antagonists; Time in therapeutic range; Cardiovascular events;
Keywords: زمان در محدوده درمانی; OAC; Oral anticoagulant; VKA; Vitamin K antagonist; DOAC; Direct oral anticoagulant; PCC; Prothrombin complex concentrate; 4F-PCC; Four factor PCC; 3F-PCC; Three factor PCC; aPCC; Activated PCC; FFP; Fresh frozen plasma; AF; Atrial fibrillation; TE; Throm
Keywords: زمان در محدوده درمانی; AF; atrial fibrillation; CHA2DS2-VASc; congestive heart failure, hypertension, age â¥75 years, diabetes mellitus, stroke/transient ischemic attack, vascular disease, age 65 to 74 years, sex category; HR; hazard ratio; ICD-9; International Classification
Keywords: زمان در محدوده درمانی; Atrial fibrillation; Dementia; Cognitive decline; Oral anticoagulant therapy; Time in therapeutic range;
Keywords: زمان در محدوده درمانی; Prothrombin time-international normalized ratio; oral anticoagulant; atrial fibrillation; warfarin; time in therapeutic range; DOAC;
Keywords: زمان در محدوده درمانی; AF; atrial fibrillation; ATT; antithrombotic treatment; CHA2DS2-VASc; congestive heart failure, hypertension, age â¥75 years, diabetes mellitus, stroke or transient ischemic attack, vascular disease, age 65-74 years, female sex category; EORP-AF; EURObse
Keywords: زمان در محدوده درمانی; Anticoagulation; Atrial fibrillation; Rosendaal; Time in therapeutic range; Warfarin;
Keywords: زمان در محدوده درمانی; Fibrilación auricular; Anticoagulación; Calidad; Tiempo en rango terapéutico; Atrial fibrillation; Anticoagulation; Quality; Time in therapeutic range;
Keywords: زمان در محدوده درمانی; anticoagulation; bleeding risk; stroke prevention; AF; atrial fibrillation; b.i.d.; twice daily; CKD; chronic kidney disease; ESRD; end-stage renal disease; FDA; Food and Drug Administration; NOAC; non-vitamin K antagonist oral anticoagulant; TTR; time i
Keywords: زمان در محدوده درمانی; ACC; Anticoagulation Clinics; AF; Atrial Fibrillation; DC; Direct Current; INR; International Normalised Ratio; PHCC; Primary Health Care Centers; TTR; Time in Therapeutic Range; TIA; Transient Ischemic Attack; anticoagulation; primary care; anticoagulati
Keywords: زمان در محدوده درمانی; Digoxin; Atrial fibrillation; Anticoagulation; Time in therapeutic range; Mortality;
Keywords: زمان در محدوده درمانی; AF; atrial fibrillation; APT; antiplatelet therapy; BARC; Bleeding Academic Research Consortium; CHA2DS2-VASc; congestive heart failure, hypertension, age ⥠75 years (doubled), diabetes, stroke (doubled), vascular disease, age 65 to 74 years, sex catego
Keywords: زمان در محدوده درمانی; ACEi; angiotensin-converting enzyme inhibitor; AF; atrial fibrillation; A-II; angiotensin-II; ANP; atrial natriuretic peptide; ARB; angiotensin receptor blocker; BP; blood pressure; BMI; body mass index; BNP; brain natriuretic peptide; CaMKII; calmodulin-
Keywords: زمان در محدوده درمانی; AF; atrial fibrillation; BMI; body mass index; CI; confidence interval; HDL-C; high-density lipoprotein cholesterol; HR; hazard ratio; INR; international normalized ratio; LDL-C; low-density lipoprotein cholesterol; NOAC; non-vitamin K antagonist oral a
Keywords: زمان در محدوده درمانی; GD; genotype-guided dosing; HR; hazard ratio; INR; international normalized ratio; MD; mean difference; RCT; randomized controlled trial; RR; risk ratio; TMD; time to maintenance dose; TTR; time in therapeutic range;
Keywords: زمان در محدوده درمانی; TTR; Time in Therapeutic Range; AF; Atrial fibrillation; OR; Odds ratio; CI; Confidence interval; TIA; Transient ischemic attack; SD; Standard deviation; INR; International Normalized Ratio; TTR; Warfarin; Mechanical heart valve prosthesis;
Keywords: زمان در محدوده درمانی; INR; international normalised ratio; OAT; oral anticoagulant treatment; AF; atrial fibrillation; DVT; deep venous thrombosis; PE; pulmonary embolism; MI; post myocardial infarction; VKA; vitamin K antagonists; TR; therapeutic range; TTR; Time in therapeut
Keywords: زمان در محدوده درمانی; VTE; venous thromboembolism; VKA; vitamin K antagonist; TTR; time in therapeutic range; PINRR; proportion of INR measurements in range; INR; international normalized ratio; CI; confidence interval; UK; United Kingdom; RCT; randomized controlled trial; ICH
Keywords: زمان در محدوده درمانی; AF; Atrial fibrillation; OAC; Oral anticoagulant; INR; International normalised ratio; TTR; Time in therapeutic range; NOAC; Novel oral anticoagulant; ARISTOTLE; Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation; AVER
Keywords: زمان در محدوده درمانی; Non-valvular Atrial Fibrillation; Warfarin; Time in therapeutic range;
Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trials
Keywords: زمان در محدوده درمانی; Atrial fibrillation; Oral anticoagulation; Aspirin; Time in therapeutic range; Major adverse outcomes;
Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation
Keywords: زمان در محدوده درمانی; Oral anticoagulation; Time in therapeutic range; Atrial fibrillation; Stroke;
Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study
Keywords: زمان در محدوده درمانی; HeartMate 3; INR management; left ventricular assist device; LVAD; reduced intensity anti-coagulation; Rosendaal method; TTR; time in therapeutic range;
Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol
Keywords: زمان در محدوده درمانی; atrial fibrillation; vitamin K antagonists; time in therapeutic range; mortality;
A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real-World” vs Clinical Trials
Keywords: زمان در محدوده درمانی; AF; atrial fibrillation; AMADEUS; Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation; CHA2DS2-VASc; Congestive heart failure or left ventricular dysfunction (1), Hypertension (1), Ageâ¥75 (2) or 65-74
Bleeding predictors in patients following venous thromboembolism treated with vitamin K antagonists: Association with increased number of single nucleotide polymorphisms
Keywords: زمان در محدوده درمانی; Venous thromboembolism; Vitamin K antagonists; Acenocoumarol; Warfarin; Genetic polymorphisms; AF; atrial fibrillation; APOE; apolipoprotein E; AUC; area under the curve; CI; confidence interval; CRNM bleeding; clinically relevant non-major bleeding; CYP2
Integrating genotypes in the SAMe-TT2R2 score for the prediction of anticoagulation control in Chinese patients with atrial fibrillation on warfarin
Keywords: زمان در محدوده درمانی; SAMe-TT2R2 score; Atrial fibrillation; Genotype; Anticoagulation; Time in therapeutic range;
Oral anticoagulation in octogenarians with atrial fibrillation
Keywords: زمان در محدوده درمانی; Atrial fibrillation; Time in therapeutic range; Vitamin K antagonists; Age; Octogenarians;
Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation
Keywords: زمان در محدوده درمانی; AF; atrial fibrillation; CHA2DS2-VASc; congestive heart failure (1 point), hypertension (1 point), age 65-74 years (1 point) and age â¥75 years (2 points), diabetes mellitus (1 point), prior stroke or transient ischemic attack (2 points), vascular dise
Assessment of Degree of Anticoagulation Control in Patients With Atrial Fibrillation in Primary Health Care in Galicia, Spain: ANFAGAL Study
Keywords: زمان در محدوده درمانی; Nonvalvular atrial fibrillation; Anticoagulation; Primary health care; Fibrilación auricular no valvular; Anticoagulación; Atención primaria; AF; atrial fibrillation; TTR; time in therapeutic range; VKA; vitamin K antagonist;
APOLLO I: Anticoagulation control in atrial fibrillation
Keywords: زمان در محدوده درمانی; Atrial fibrillation; Anticoagulants; Time in therapeutic range; Fibrilhação auricular; Anticoagulantes; Tempo em alvo terapêutico;
APOLO I: controlo da hipocoagulação na fibrilhação auricular
Keywords: زمان در محدوده درمانی; Fibrilhação auricular; Anticoagulantes; Tempo em alvo terapêuticoAtrial fibrillation; Anticoagulants; Time in therapeutic range
Direct Oral Anticoagulants in Patients With VTE and Cancer
Keywords: زمان در محدوده درمانی; CLOT; Comparison of Low-Molecular-Weight Heparin vs Oral Anticoagulant Therapy for Long-Term Anticoagulation in Cancer Patients With Venous Thromboembolism; DOA; direct oral anticoagulant; LMWH; low-molecular-weight heparin; RCT; randomized clinical trial
The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study
Keywords: زمان در محدوده درمانی; Acenocoumarol; Anticoagulation; Atrial fibrillation; Time in therapeutic range;
Impact of short periods with worsened or improved INR control on life expectancy and QALYs in patients with atrial fibrillation
Keywords: زمان در محدوده درمانی; AF; Atrial Fibrillation; INR; International Normalized Ratio; QALY; Quality-Adjusted Life Years; SD; Standard Deviation; SDTINR; Standard Deviation of Transformed International Normalized Ratio; TTR; Time in Therapeutic Range; Warfarin; Atrial fibrillatio
Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: Results from the ROCKET AF trial
Keywords: زمان در محدوده درمانی; AAD; antiarrhythmic drug; AF; atrial fibrillation; CI; confidence interval; CNS; central nervous system; ED; emergency department; GI; gastrointestinal; HR; hazard ratio; INR; international normalized ratio; MI; myocardial infarction; NMCR; nonmajor clini
The Anticoagulation of Calf Thrombosis (ACT) Project
Keywords: زمان در محدوده درمانی; AE; adverse event; ARR; absolute risk reduction; IDDVT; isolated distal DVT; INR; international normalized ratio; RCT; randomized controlled trial; TTR; time in therapeutic range;
Computer aided warfarin dosing in the Swedish national quality registry AuriculA - Algorithmic suggestions are performing better than manually changed doses
Keywords: زمان در محدوده درمانی; INR; International Normalised Ratio; TTR; Time in Therapeutic Range; cTTR; Center Time in Therapeutic Range; Anticoagulation; Atrial fibrillation; Computer-assisted therapy; INR; Warfarin;
Tiempo en rango terapéutico de los pacientes que siguen tratamiento con derivados cumarÃnicos en la práctica clÃnica diaria
Keywords: زمان در محدوده درمانی; Anticoagulación oral; Fibrilación auricular; Tiempo en rango terapéutico; Oral anticoagulation; Atrial fibrilation; Time in therapeutic range;
Quality of individual INR control and the risk of stroke and bleeding events in atrial fibrillation patients: A nested case control analysis of the ACTIVE W study
Keywords: زمان در محدوده درمانی; ACTIVE W; the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events; VKA; vitamin K antagonist; AF; atrial fibrillation; INR; international normalized ratio; TTR; time in therapeutic range; SD; standard deviation; Anticoa
Identifying Potential Predictors of High-Quality Oral Anticoagulation Assessed by Time in Therapeutic International Normalized Ratio Range: A Prospective, Long-Term, Single-Center, Observational Study
Keywords: زمان در محدوده درمانی; anticoagulation; quality of health care; time in therapeutic range; warfarin
EMPoWarMENT: Edmonton Pediatric Warfarin Self-Management Pilot Study in Children with Primarily Cardiac Disease
Keywords: زمان در محدوده درمانی; INR; International normalized ratio; PST; patient self testing; PSM; Patient self management; QOL; Quality of life; TTR; Time in therapeutic range; VPaT; Vascular Patency and Thrombosis; KIDCLOT PAC QL; Kids informed decrease complications, Learning on Th
Changes in surrogate outcomes can be translated into clinical outcomes using a Monte Carlo model
Keywords: زمان در محدوده درمانی; Surrogate outcomes; Randomized trials; Monte Carlo simulation; Oral anticoagulation; Minimal important difference; Time in therapeutic range
The interval between prothrombin time tests and the quality of oral anticoagulants treatment in patients with chronic atrial fibrillation
Keywords: زمان در محدوده درمانی; AF; atrial fibrillation; TTR; time in therapeutic range; AC; anticoagulation; OAC; oral anticoagulants; PT; prothrombin time; ACCP; The American Collage of Chest Physician; Atrial fibrillation; Warfarin; Quality of treatment;